Roquette, a global leader in plant-based ingredients, pioneer of plant proteins and world-leading provider of pharmaceutical excipients, has today announced the launch of its ready-to-use, pharmaceutical grade solution for vegetarian softgel capsule formulation – LYCAGEL® Premix. Developed based on Roquette’s market-first pea starch technology – LYCAGEL® – launched in 2020, the new softgel blend provides manufacturers with an easy-to-use and convenient solution that ensures fast and reproducible scale-up for both nutraceutical and pharmaceutical applications.

A complete, plant-based powder, LYCAGEL® Premix enables capsule characteristics comparable to gelatin softgels, including excellent capsule strength, seal integrity, quick drying time with no stickiness, fast disintegration, and improved performance thanks to high thermal and chemical stability. Supporting non-GMO, halal, kosher and clean-label claims, LYCAGEL® Premix offers manufacturers an easy-to-use solution which eliminates dosing steps.

“Accessing the right quantities of raw materials is not always straightforward. LYCAGEL® Premix eliminates the need for manufacturers to manage multiple raw material inventory and simplifies processes, like handling and storage, as well as streamlining manufacturing through the simple addition of water and glycerol to the powder,” said Paul Smaltz, Vice President of Roquette Pharmaceutical Solutions.

Smaltz adds: “Available as a drop-in solution for customers’ existing systems, it is now easy for manufacturers to adopt the premix into current manufacturing set-ups without requiring re-tooling of the line. This eliminates the need for dosing of individual ingredients, while also minimizing the risk of variability and probability of production failure. We look forward to seeing what the future holds for LYCAGEL® Premix.”

LYCAGEL® Premix is available with immediate effect – for more information, please visit: https://roquette.campaign.page/lycagel. 

About Roquette: “Offering the best of nature”

Roquette is a global leader in plant-based ingredients, a pioneer of plant proteins and a leading provider of pharmaceutical excipients. In collaboration with its customers and partners, the group addresses current and future societal challenges by unlocking the potential of nature to offer the best ingredients for food, nutrition and health markets.

These ingredients respond to unique and essential needs, enable healthier lifestyles and are critical components of life-saving medicines.

Thanks to a constant drive for innovation and a long-term vision, the group is committed to improving the well-being of millions of people all over the world while taking care of resources and territories.

Roquette currently operates in over 100 countries, has a turnover of around 3.5 billion euros and employs 8,360 people worldwide. www.roquette.com.

Registered trademark of Roquette Frères, its affiliates or subsidiaries in the United States and certain other countries

MEDIA CONTACTS

Corporate Communications

Carole Petitjean

carole.petitjean@roquette.com

Global Pharmaceutical Communications

Emily Delommez

emily.delommez@roquette.com   

Report Abuse